Correction to: Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer.
Yuan LiWeili ZhangJie DuJinlong HuRuixi HuZiyang ZengE-Er-Man-Bie-Ke Jin-Si-HanShaopu LianHao WangYunfeng LiZhizhong PanCheng FengXuan ZhangZhen-Hai LuPublished in: Targeted oncology (2024)